NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,239 filers reported holding NOVARTIS A G in Q1 2024. The put-call ratio across all filers is 0.75 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $1,051,931 | +9.6% | 9,881 | -0.4% | 0.05% | 0.0% |
Q1 2024 | $959,658 | -3.6% | 9,921 | +0.6% | 0.05% | -18.3% |
Q4 2023 | $995,261 | -0.9% | 9,857 | 0.0% | 0.06% | -18.9% |
Q3 2023 | $1,004,034 | +0.2% | 9,857 | -0.7% | 0.07% | +89.7% |
Q2 2023 | $1,001,734 | +12.8% | 9,927 | +2.9% | 0.04% | -51.2% |
Q1 2023 | $887,892 | +1.4% | 9,651 | 0.0% | 0.08% | -14.9% |
Q4 2022 | $875,539 | +19.4% | 9,651 | +0.1% | 0.09% | +168.6% |
Q3 2022 | $733,000 | -7.6% | 9,641 | +2.8% | 0.04% | -5.4% |
Q2 2022 | $793,000 | -5.8% | 9,381 | -2.2% | 0.04% | +8.8% |
Q1 2022 | $842,000 | +1.3% | 9,592 | +0.9% | 0.03% | +25.9% |
Q4 2021 | $831,000 | +7.1% | 9,502 | +0.2% | 0.03% | -80.1% |
Q3 2021 | $776,000 | -17.5% | 9,485 | -8.0% | 0.14% | -20.0% |
Q2 2021 | $941,000 | +7.3% | 10,309 | +0.5% | 0.17% | -4.0% |
Q1 2021 | $877,000 | +5.2% | 10,256 | +16.2% | 0.18% | -7.8% |
Q4 2020 | $834,000 | +9.0% | 8,829 | +0.3% | 0.19% | -5.0% |
Q3 2020 | $765,000 | +8.7% | 8,802 | +9.2% | 0.20% | -0.5% |
Q2 2020 | $704,000 | +12.3% | 8,063 | +6.1% | 0.20% | -3.8% |
Q1 2020 | $627,000 | -8.3% | 7,603 | +5.3% | 0.21% | +11.6% |
Q4 2019 | $684,000 | +9.1% | 7,219 | 0.0% | 0.19% | -1.0% |
Q3 2019 | $627,000 | -52.4% | 7,219 | -50.0% | 0.19% | -6.8% |
Q2 2019 | $1,318,000 | +78.3% | 14,438 | +87.9% | 0.20% | -13.5% |
Q1 2019 | $739,000 | -6.9% | 7,685 | -17.0% | 0.24% | -13.2% |
Q4 2018 | $794,000 | -50.3% | 9,258 | -50.0% | 0.27% | +1.5% |
Q3 2018 | $1,596,000 | +121.1% | 18,516 | +93.6% | 0.27% | +1.5% |
Q2 2018 | $722,000 | -6.6% | 9,563 | +0.1% | 0.26% | -12.0% |
Q1 2018 | $773,000 | -4.8% | 9,556 | -1.2% | 0.30% | -5.6% |
Q4 2017 | $812,000 | -8.1% | 9,671 | -6.1% | 0.32% | -14.2% |
Q3 2017 | $884,000 | +9.1% | 10,299 | +6.1% | 0.37% | +1.1% |
Q2 2017 | $810,000 | +20.2% | 9,710 | +7.0% | 0.37% | +16.5% |
Q1 2017 | $674,000 | 0.0% | 9,078 | -1.8% | 0.32% | -7.1% |
Q4 2016 | $674,000 | -7.5% | 9,249 | +0.2% | 0.34% | -14.8% |
Q3 2016 | $729,000 | -3.1% | 9,228 | +1.2% | 0.40% | -8.3% |
Q2 2016 | $752,000 | – | 9,120 | – | 0.44% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Martin Investment Management, LLC | 318,637 | $27,960,000 | 7.08% |
MANAGED ASSET PORTFOLIOS, LLC | 417,183 | $36,608,000 | 5.02% |
SAL Trading, LLC | 233,600 | $20,498,000 | 4.77% |
SCHARF INVESTMENTS, LLC | 1,340,680 | $117,662,000 | 3.49% |
SAL Trading, LLC | 155,783 | $13,670,000 | 3.18% |
First Fiduciary Investment Counsel, Inc. | 169,371 | $14,862,000 | 2.90% |
PRENTISS SMITH & CO INC | 55,026 | $4,829,000 | 2.90% |
GARLAND CAPITAL MANAGEMENT INC | 47,630 | $4,180,000 | 2.77% |
Cullen Capital Management, LLC | 3,295,271 | $289,160,000 | 2.66% |
WILKINS INVESTMENT COUNSEL INC | 133,880 | $11,748,000 | 2.65% |